Kidney involvement in tuberous sclerosis complex: the impact on healthcare resource use and costs

References

• Evans LT, Morse R, Roberts DW. Epilepsy surgery in tuberous sclerosis: a review. Neurosurg Focus 2012;32:E5
   Web of Science ®Google Scholar
• Joinson C, O’Callaghan FJ, Osborne JP, et al. Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex. Psychol Med 2003;33:335-44
   PubMed Web of Science ®Google Scholar
• Tuberous Sclerosis Alliance. Mental retardation in tuberous sclerosis complex. Silver Spring, MD: Tuberous Sclerosis Alliance, 2006. http://www.tsalliance.org/documents/Mental%20Retardation%20in%20TSC.pdf. Accessed November 5, 2014
   Google Scholar
• Tuberous Sclerosis Alliance. Lung involvement in TSC. Silver Spring, MD: Tuberous Sclerosis Alliance, 2013. http://www.tsalliance.org/documents/LUNG%20INVOLVEMENT%20IN%20TSC%20(updated%20Nov%202013).pdf. Accessed July 2, 2015
   Google Scholar
• Hallett L, Foster T, Liu Z, et al. Burden of disease and unmet needs in tuberous sclerosis complex with neurological manifestations: systematic review. Curr Med Res Opin 2011;27:1571-83
   PubMed Web of Science ®Google Scholar
• Capurro S, Fiallo P. Timed surgery for treatment of angiofibromas in tuberous sclerosis. Dermatol Surg 2001;27:486-8
   PubMed Web of Science ®Google Scholar
• Lennert B, Farrelly E, Sacco P, et al. Resource utilization in children with tuberous sclerosis complex and associated seizures: a retrospective chart review study. J Child Neurol 2013;28:461-9
   PubMed Web of Science ®Google Scholar
• Mayo Clinic. Tuberous sclerosis. Rochester, MN: Mayo Clinic, 2014. http://www.mayoclinic.com/health/tuberous-sclerosis/DS01032/DSECTION=treatments-and-drugs. Accessed July 31, 2015
   Google Scholar
• Pirson Y. Tuberous Sclerosis Complex-associated kidney angiomyolipoma. Nephrol Dial Transplant 2013;28:1680-5
   PubMed Web of Science ®Google Scholar
• Krueger DA, Northrup H, on behalf of the International Tuberous Sclerosis Complex Consensus Group. Tuberous Sclerosis Complex Surveillance and Management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 2013;49:255-65
   PubMed Web of Science ®Google Scholar
• Rouvière O, Nivet H, Grenier N, et al. Kidney damage due to tuberous sclerosis complex: Management recommendations. Diagn Interv Imaging 2013;94:225-37
   PubMedGoogle Scholar
• Franz DN, Belousova E, Sparagana S. Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial. Lancet 2013;381:125-32
   PubMed Web of Science ®Google Scholar
• Bissler J, Kingswood JC, Radzikowska E, et al. Everolimus for angiomyolipoma associated with tuberous sclerosis comples or sporadic lymphangioleiomyomatosis (EXIST-2): a multicenter, randomized, double-blind, placebo-controlled trial. Lancet 2013;381:817-24
   PubMed Web of Science ®Google Scholar
• Roach ES, Gomez MR, Northrup H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol 1998;13:624-8
   PubMed Web of Science ®Google Scholar
• Eckardt KU, Berns JS, Rocco MV, et al. Definition and classification of CKD: the debate should be about patient prognosis – A position statement from KDOQI and KDIGO. Am J Kidney Dis 2009;53:915-20
   PubMed Web of Science ®Google Scholar
• National Kidney Foundation. Calculators for health care professionals. New York, NY: National Kidney Foundation, 2013. http://www.kidney.org/professionals/kdoqi/gfr_calculator.cfm. Accessed June 10, 2014
   Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-12
   PubMed Web of Science ®Google Scholar
• Wetzels JFM, Kiemeney LALM, Swinkels DW, et al. Age- and gender-specific reference values of estimated GFR in Caucasians: The Nijmegen Biomedical Study. Kidney Int 2007;72:632-7
   PubMed Web of Science ®Google Scholar
• Van den Brand JAJG, van Boekel GAJ, Willems HL, et al. Introduction of the CKD-EPI equation to estimate glomerular filtration rate in a Caucasian population. Nephrol Dial Transplant 2011;26:3176-81
   PubMed Web of Science ®Google Scholar
• Zorginstituut Nederland. Medication Costs. Amsterdam: Zorginstituut Nederland, 2012. http://www.medicijnkosten.nl/. Accessed 2012
   Google Scholar
• Nederlandse Zorgautoriteit. DBC zorgproducten tariefapplicatie. Utrecht: Nederlandse Zorgautoriteit, 2014. http://dbc-zorgproducten-tarieven.nza.nl/nzaZpTarief/ZoekfunctieDbc.aspx. Accessed October 31, 2014
   Google Scholar
• The Renal Association. CKD stages. Petersfield: The Renal Association, 2013. http://www.renal.org/information-resources/the-uk-eckd-guide/ckd-stages#sthash.hy4VyJRL.ylqkO4Lq.dpbs. Accessed September 2, 2014
   Google Scholar
• American Heart Association. Understanding blood pressure readings. Dallas, TX: American Heart Association, 2014. http://www.heart.org/HEARTORG/Conditions/HighBloodPressure/AboutHighBloodPressure/Understanding-Blood-Pressure-Readings_UCM_301764_Article.jsp. Accessed September 2, 2014
   Google Scholar
• Rakowski SK, Winterkorn EB, Paul E, et al. Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors. Kidney Int 2006;70:1777-82
   PubMed Web of Science ®Google Scholar
• Eijkemans MJC, van der Wal W, Reijnders LJ, et al. Long-term follow-up assessing renal angiomyolipoma treatment patterns, morbidity and mortality: an observational study in tuberous sclerosis complex patients in the Netherlands. Am J Kidney Dis 2015;S0272-6386:00845-8 (Epub ahead of print)
   Google Scholar
• Schillinger F, Montagnac R. Chronic renal failure and its treatment in tuberous sclerosis. Nephrol Dial Transpl 1996;11:481-5
   PubMed Web of Science ®Google Scholar